Status:
COMPLETED
Effect of Pre-operative Depo Medroxyprogesterone Acetate on Serum Anti-mullerian Hormone Level After Laparoscopic Ovarian Cystectomy of Endometriomas
Lead Sponsor:
Mahidol University
Conditions:
Endometriosis
Eligibility:
FEMALE
18-40 years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to evaluate the ovarian reserve changes after preoperative depot medroxyprogesterone acetate (DMPA) in women with ovarian endometrioma undergoing laparoscopic cystectomy.
Eligibility Criteria
Inclusion
- Healthy women 18-40 years old
- A diagnosis of endometrioma with diameter of at least 3 cm.
- Candidates for laparoscopic cystectomy
Exclusion
- Patients' refusal to participate
- Not candidate for depot medroxyprogesterone acetate such as: cirrhosis, chronic kidney disease, venous thrombosis
- Use of estrogen-suppressive drugs in the preceding 3 months, such as:
- Oral contraceptives, GnRH analogues, Progestins, Danazol
- Pathology report present no endometriosis
Key Trial Info
Start Date :
March 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01791413
Start Date
March 1 2012
End Date
March 1 2013
Last Update
September 9 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Obstetrics and Gynecology
Ratchathewi, Bangkok, Thailand, 10400